GlassScriptPhysician profile
Michael T Ruk
NPI 1356343255
$2,968.92
in general payments reported to CMS, 2019-2025
34 companies · $450 in 2025
The $450 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $259 · 2021: $581 · 2022: $577 · 2023: $529 · 2024: $322 · 2025: $450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,274 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,274.09 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $503.96 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Exeltis, USA INC. | $355.70 | 2019-2025 | Slynd |
| Millicent US INC | $233.24 | 2021-2025 | Intrarosa, Femring, Femlyv |
| Pfizer INC. | $211.19 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $202.74 | 2023-2025 | Myfembree |
| Sage Therapeutics, LLC | $141.55 | 2024-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $113.06 | 2021-2025 | |
| Therapeuticsmd, INC. | $109.99 | 2020-2022 | |
| Astellas Pharma US INC | $101.90 | 2021-2025 | Veozah |
| Aspira Women'S Health INC | $96.95 | 2022 | |
| Hologic Sales and Service, LLC | $95.63 | 2019-2023 | Acessa Provu System, Novasure, Myosure Tissue Removal Device |
| Organon LLC | $88.51 | 2022-2024 | Nexplanon |
| Evofem Biosciences, INC. | $60.68 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $58.98 | 2019-2021 | |
| Exact Sciences Corporation | $58.64 | 2023-2025 | Cologuard Collection Kit |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $54.78 | 2021-2022 | |
| Avion Pharmaceuticals | $49.60 | 2021-2023 | Balcoltra |
| Mylan Pharmaceuticals INC. | $40.74 | 2019-2021 | |
| Meditrina | $38.76 | 2022-2025 | |
| Coopersurgical, INC. | $36.38 | 2020-2025 | |
| Lupin INC. | $35.46 | 2020-2021 | |
| Mycovia Pharmaceuticals, INC. | $33.95 | 2022-2023 | Vivjoa |
| Myovant Sciences INC. | $32.54 | 2021-2022 | |
| Vertical Pharmaceuticals, LLC | $29.15 | 2019-2020 | |
| Innovation Technologies INC | $24.81 | 2023 | Irrisept |
| Minerva Surgical, INC | $23.94 | 2022 | |
| Medtronic, INC. | $22.93 | 2023 | V-Loc 180 |
| Integra Lifesciences Corporation | $20.64 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $19.50 | 2022 | |
| Smith+Nephew, INC. | $18.35 | 2019 | |
| Supernus Pharmaceuticals, INC. | $16.03 | 2025 | Qelbree |
| Ethicon US, LLC | $14.18 | 2023 | Vistaseal, Surgicel Nu-Knit, Stratafix |
| Duchesnay USA Incorporated | $13.67 | 2019 | |
| Amag Pharmaceuticals, INC. | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ruk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.